The Effect Of Insulin Glargine And Fish Oil Supplements On Atherosclerosis Progression In High-Risk Patients With Type 2 Diabetes Or Pre-Diabetes

A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of ra...

via Medical News Today